Saturday 17 October 2026
Export CABR’s income statement to Excel — free account
Caring Brands, Inc.
CABR Healthcare Drug Manufacturers Specialty & Generic
Caring Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4,200.00, up 740.0% from fiscal 2024. In the quarter to June 2026, EPS fell 102.0% and free cash flow fell 121.3%, each against the same quarter a year earlier.
1.22
0.07
−5.43%
Follow CABR
| Dec '25 | Dec '24 | |
|---|---|---|
P/E ratio |
0.00 | 0.00 |
Altman Z-Score |
18.05 | — |
P/S ratio |
2,777.62 | 0.00 |
P/FCF ratio |
0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(11.76) | 18.03 |
P/Operating CF |
(11.00) | (61.69) |
P/B ratio |
5.58 | 4.29 |
Price to Tangible BV |
0.00 | 0.00 |
EV/Sales |
2,270.35 | 0.00 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
(5.63) | (12.32) |
EV/FCF |
(5.63) | (12.32) |
Quick Ratio |
12.38 | 2.52 |
Current Ratio |
13.16 | 2.83 |
Net Debt/EBITDA |
0.38 | 0.34 |
Debt/Assets |
2.52% | 0.00% |
Debt/Equity |
0.03 | 0.00 |
Asset Turnover |
0.00 | 0.00 |
Operating CF/Net income |
0.27 | 0.54 |
Capex/Depreciation |
0.00 | 0.00 |
Interest Coverage |
(309.11) | 152.74 |
| (217.14%) | 0.00% | |
| (202.38%) | 0.00% | |
ROIC |
0.00% | (29.62%) |
Return on Tangible Assets |
(292.01%) | (444.46%) |
Average Days of Receivables |
0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
3,516.67% | 20,660.00% |
Intangible Assets out of Total Assets |
0.00 | 0.74 |
Share Based Compensation of Revenue |
29,492.86% | 80,000.00% |
Graham Net Nets |
0.18 | (0.05) |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
(53.52%) | (26.04%) |
Free Cash Flow Yield |
(14.51%) | (8.11%) |
Revenue per Share |
0.00 | 0.00 |
Operating CF per Share |
(0.12) | (0.06) |
Capex per Share |
0.00 | 0.00 |
Free Cash Flow per Share |
(0.12) | (0.06) |
Cash per Share |
0.16 | 0.04 |
Shareholders Equity per Share |
0.15 | 0.28 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
0.15 | 0.28 |
Free Cash Flow |
(1.69) | (0.82) |
Working Capital |
2.15 | 0.34 |
Net Current Asset Value |
2.09 | 0.34 |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
0.00 | 0.00 |
Cash ROIC |
(39.00%) | (19.81%) |
Accounts Receivable Turnover |
0.00 | 0.00 |
Accounts Payable Turnover |
0.01 | 0.00 |
Inventory Turnover |
0.14 | 0.00 |
Average Days of Payables |
32,734.74 | 29,443.33 |
Days of Inventory on Hand |
2,458.95 | 2,381.19 |
Average Payables |
0.17 | — |
Average Inventory |
0.01 | — |
Average Assets |
3.10 | — |
Average Common Equity |
2.89 | — |
Columns are period end dates